Activities of Renate SOMMER related to 2013/2022(INI)
Shadow reports (1)
REPORT on the report from the Commission to the Council on the basis of Member States' reports on the implementation of the Council Recommendation (2009/C 151/01) on patient safety, including the prevention and control of healthcare- associated infections PDF (244 KB) DOC (139 KB)
Amendments (14)
Amendment 38 #
Motion for a resolution
Recital C
Recital C
C. whereas the most common healthcare- related adverse events are healthcare associated infections (HAIs), medication- related events, including those resulting from off-label use, and complications arising during or after surgical operations;
Amendment 50 #
Motion for a resolution
Recital I a (new)
Recital I a (new)
Ia. whereas the European Centre for Disease Prevention and Control (ECDC), with the involvement of international experts, has the task of developing scientific recommendations on evidence- based measures for the effective prevention of HAIs;
Amendment 54 #
Motion for a resolution
Recital E a (new)
Recital E a (new)
Ea. whereas the financial and economic crisis and the budget cuts which it necessitated may in some Member States lead, or already have led, to an increased incidence of patients being prescribed cheaper off-label medicines;
Amendment 72 #
Motion for a resolution
Recital K a (new)
Recital K a (new)
Ka. whereas demographic changes are leading to an increase in the proportion of older patients, who are frequently prescribed a large number of different medicines but are often unable to cope with taking them correctly;
Amendment 108 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Criticises the fact that, to date, no classification or reporting system for patient safety has been proposedexists at EU level for the purpose of identifying, understanding and analysing the factors involved in patient safety, with a view to learning and improving the relevant systems;
Amendment 132 #
Motion for a resolution
Paragraph 11 a (new)
Paragraph 11 a (new)
11a. Calls on the European Medicines Agency (EMA) to draw up a list of off- label medicines which are used in spite of there being an approved alternative; calls on the Member States to ensure that medical professionals and patients are informed when a medicine is used off- label;
Amendment 147 #
Motion for a resolution
Paragraph 16 – introductory part
Paragraph 16 – introductory part
16. Urges the Member States to continue their effortsset clear national targets for the reduction of HAIs and to implement, if they have not already done so, additional measures to reduce the number of HAIs, with a view to falling fully into line with the Council’s recommendations, and in particular measures to:
Amendment 149 #
Motion for a resolution
Paragraph 16 – indent 2
Paragraph 16 – indent 2
– improve the information provided to patients by and outside healthcarhealthcare establishments, including information on the prevalence of HAIs in these establishments;
Amendment 159 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18a. Calls on the Member States to introduce mandatory screening of patients for antibiotic-resistant microbes ahead of scheduled hospital stays and outpatient surgery, in order to prevent the spread of these microbes and ensure legal certainty;
Amendment 162 #
Motion for a resolution
Paragraph 19
Paragraph 19
19. Calls on the Member States and the Commission to foster, including by means of good practices and awareness-raising campaigns, good practices in all areas, in the areas prioritised by the ECDC – such as the prevention of vascular catheter associated infections – in particular all those linked to hygiene (hand hygiene, sterilisation of instruments, etc.) both in and outside hospital (in particular vis-à-vis patients and their families and outpatient care staff);
Amendment 191 #
Motion for a resolution
Paragraph 24 a (new)
Paragraph 24 a (new)
24a. Calls on the Member States to involve patient organisations in the development of new laws and health programmes;
Amendment 199 #
Motion for a resolution
Paragraph 27
Paragraph 27
Amendment 213 #
Motion for a resolution
Paragraph 29
Paragraph 29
29. Urges the Member States to adopt standardised criteria to identify places where contamination with HAIs occurs (including facilities outside hospitals) and to continue their efforts to collect comparable, up-to-date information on general patient safety and HAIs; calls on the Member States to publish this data on an annual basis;
Amendment 233 #
Motion for a resolution
Paragraph 35 a (new)
Paragraph 35 a (new)
35a. Calls on the European Medicines Agency to develop guidelines on the off- label use of medicines on the basis of medical need and taking account of patient protection;